Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib in Intracerebral Hemorrhage
NCT05434065Phase 2Recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- Jan 2023
- Primary completion
- Jul 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib in intracerebral hemorrhage (ICH), sponsored by National Taiwan University Hospital. Started Jan 2023; status: recruiting.
02
Drugs
celecoxib
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT05434065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05434065.